Qube Research & Technologies (QRT)
SWTX

Qube Research & Technologies (QRT)’s SpringWorks Therapeutics SWTX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-51,529
Closed -$2.42M – 3939
2025
Q2 		$2.42M Sell
51,529
-392,844
-88% -$17.5M ﹤0.01% 2122
2025
Q1 		$19.6M Buy
444,373
+308,290
+227% +$14.2M 0.02% 761
2024
Q4 		$4.92M Sell
136,083
-186,003
-58% -$6.5M 0.01% 1507
2024
Q3 		$10.3M Buy
322,086
+126,690
+65% +$4.73M 0.02% 1026
2024
Q2 		$7.36M Buy
195,396
+171,202
+708% +$7.21M 0.01% 1074
2024
Q1 		$1.19M Buy
+24,194
New +$1.12M ﹤0.01% 2040
2023
Q3 		– Sell
-22,549
Closed -$591K – 4327
2023
Q2 		$591K Buy
+22,549
New +$593K ﹤0.01% 1475
2022
Q1 		– Sell
-8,297
Closed -$514K – 2988
2021
Q4 		$514K Buy
8,297
+3,013
+57% +$199K ﹤0.01% 1554
2021
Q3 		$335K Buy
+5,284
New +$407K ﹤0.01% 1438
2021
Q2 		– Sell
-3,499
Closed -$257K – 2783
2021
Q1 		$257K Buy
+3,499
New +$274K ﹤0.01% 1532
2020
Q2 		– Sell
-10,021
Closed -$271K – 1979
2020
Q1 		$271K Buy
+10,021
New +$327K 0.01% 765

Other funds holding SWTX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Qube Research & Technologies (QRT)'s SWTX Position: Q3 2025 in Review

Qube Research & Technologies (QRT) sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 51,529 shares — an estimated $2.42M sold.

Qube Research & Technologies (QRT) first reported a position in SWTX in Q1 2020 and held it in 11 quarters. The position peaked at $19.6M in Q1 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

  • Qube Research & Technologies (QRT) reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 51,529 SpringWorks Therapeutics shares in Q3 2025, an estimated $2.42M.
  • Qube Research & Technologies (QRT) first reported a position in SpringWorks Therapeutics in Q1 2020 and held it in 11 quarters.
  • Qube Research & Technologies (QRT)'s SpringWorks Therapeutics position peaked at $19.6M in Q1 2025.
  • 3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2025, filed 14 Nov 2025.